Assignment of the 2.03 ppm resonance in in vivo 1H MRS of human brain tumour cystic fluid: contribution of macromolecules
- PMID: 15340855
- DOI: 10.1007/s10334-004-0043-y
Assignment of the 2.03 ppm resonance in in vivo 1H MRS of human brain tumour cystic fluid: contribution of macromolecules
Abstract
MRI and MRS are established techniques for the evaluation of intracranial mass lesions and cysts. The 2.03 ppm signal recorded in their (1)H-MRS spectra is often assigned to NAA from outer volume contamination, although it has also been detected in non-infiltrating tumours and large cysts. We have investigated the molecular origin of this resonance in ten samples of cystic fluids from human brain tumours. The NMR detected content of the 2.03 ppm resonance in 136 ms echo time spectra, assuming an N- CH(3) origin, was 3.19 +/- 1.01 mM. Only one third (34 +/- 12%) of the N-acetyl containing compound (NAC) signal could be extracted by perchloric acid (PCA) indicating that most of it originated in a macromolecular PCA-insoluble component. Chemical analysis of the cyst fluids showed that sialic acid bound to macromolecules would account for 64.3% and hexuronic containing compounds for 29.2% of the NMR-detectable ex vivo signal, 93.4% of the signal at TE 136 ms. Lactate content measured by NMR (6.4 +/- 4.4 mM) and the predominance of NAC originating in sialic acid point to a major origin from tumour rather than from plasma for this 2.03 ppm resonance.
Similar articles
-
Proton magnetic resonance spectroscopy and diffusion-weighted imaging in intracranial cystic mass lesions.Surg Neurol. 2007;68 Suppl 1:S25-36. doi: 10.1016/j.surneu.2007.07.080. Surg Neurol. 2007. PMID: 17963918
-
Cystic intracranial mass lesions: possible role of in vivo MR spectroscopy in its differential diagnosis.Magn Reson Imaging. 1995;13(7):1019-29. doi: 10.1016/0730-725x(95)00045-i. Magn Reson Imaging. 1995. PMID: 8583866
-
Ex vivo proton MR spectroscopy (1H-MRS) for evaluation of human gastric carcinoma.Magn Reson Imaging. 2004 Jul;22(6):861-70. doi: 10.1016/j.mri.2004.01.045. Magn Reson Imaging. 2004. PMID: 15234456
-
Handling macromolecule signals in the quantification of the neurochemical profile.J Alzheimers Dis. 2012;31 Suppl 3:S101-15. doi: 10.3233/JAD-2012-120100. J Alzheimers Dis. 2012. PMID: 22543852 Review.
-
(1)H MR spectroscopy of human brain tumours: a practical approach.Eur J Radiol. 2008 Aug;67(2):268-274. doi: 10.1016/j.ejrad.2008.02.036. Epub 2008 Apr 14. Eur J Radiol. 2008. PMID: 18406554 Review.
Cited by
-
Delayed post-traumatic fronto-ethmoidal sinus mucocele evaluated with short and long TE MR spectroscopy.Neuroradiol J. 2013 Dec;26(6):693-8. doi: 10.1177/197140091302600613. Epub 2013 Dec 18. Neuroradiol J. 2013. PMID: 24355189 Free PMC article.
-
In vivo proton magnetic resonance spectroscopy of intraventricular tumours of the brain.Eur Radiol. 2009 Aug;19(8):2049-59. doi: 10.1007/s00330-009-1357-y. Epub 2009 Mar 11. Eur Radiol. 2009. PMID: 19277673
-
Contribution of macromolecules to brain 1 H MR spectra: Experts' consensus recommendations.NMR Biomed. 2021 May;34(5):e4393. doi: 10.1002/nbm.4393. Epub 2020 Nov 25. NMR Biomed. 2021. PMID: 33236818 Free PMC article.
-
Epithelial and stromal metabolite changes in the transition from cervical intraepithelial neoplasia to cervical cancer: an in vivo 1H magnetic resonance spectroscopic imaging study with ex vivo correlation.Eur Radiol. 2009 Aug;19(8):2041-8. doi: 10.1007/s00330-009-1363-0. Epub 2009 Mar 4. Eur Radiol. 2009. PMID: 19259678
-
A multi-centre, web-accessible and quality control-checked database of in vivo MR spectra of brain tumour patients.MAGMA. 2006 Feb;19(1):22-33. doi: 10.1007/s10334-005-0023-x. Epub 2006 Feb 14. MAGMA. 2006. PMID: 16477436
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical